Correction

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

N Engl J Med 2005; 352:1731April 21, 2005

Article

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy (Original Article, N Engl J Med 2004:351;1952 - 1961) . On page 1952, in the Abstract, the first sentence of the Results section should have stated (with revised numbers in bold): “After five years, the change in the glomerular filtration rate was –17.5 ml per minute per 1.73 m² of body-surface area, where the minus sign denotes a decrement, with telmisartan (in 103 subjects), as compared with –15.0 ml per minute per 1.73 m² with enalapril (in 113 subjects), for a treatment difference of –2.6 ml per minute per 1.73 m² (95 percent confidence interval, –7.1 to 2.0 ml per minute per 1.73 m²).”

Also, on page 1957, in the left-hand column, lines 18 through 26 of the first full paragraph should have read (with revised numbers in bold): “After five years, the mean change in the glomerular filtration rate was –17.5 ml per minute per 1.73 m² (where the minus sign denotes a decrement) in the telmisartan-treated subjects, as compared with –15.0 ml per minute per 1.73 m² in the enalapril-treated subjects; the treatment difference was thus –2.6 ml per minute per 1.73 m² (95 percent confidence interval, –7.1 to 2.0 ml per minute per 1.73 m²).”

Citing Articles (1)

Citing Articles

1. 1

   Steven G. Chrysant, George S. Chrysant. (2006) The Pleiotropic Effects of Angiotensin Receptor Blockers. The Journal of Clinical Hypertension 8:4, 261-268
   CrossRef